Indo Us Bio-Tech Complete Financial Statements
INDOUS • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2022 - 2020
Complete Financial Data Export
Export complete financial statements for Indo Us Bio-Tech (INDOUS).
Downloads include all available records across all periods.
For market performance, see the
INDOUS stock price today
.
Profitability Ratios
Net Profit Margin
10.00%
2022 data
EBITDA Margin
14.00%
2022 data
Operating Margin
14.00%
2022 data
Return on Assets
8.93%
2022 data
Return on Equity
12.82%
2022 data
Balance Sheet Ratios
Current Ratio
9.40
2022 data
Debt to Equity
1.44
2022 data
Equity Ratio
69.64%
2022 data
Asset Turnover
0.89
2022 data
Year-over-Year Growth Analysis
Comparing March 2022 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+27.3%
Year-over-Year
Equity Growth
+85.7%
Year-over-Year
Liabilities Growth
+27.3%
Year-over-Year
Investing Cash Flow Growth
-150.0%
Year-over-Year
Financing Cash Flow Growth
+50.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|
| Revenue | 0 | 50 | 40 | 40 |
| Expenses | 0 | 43 | 35 | 36 |
| EBITDA | 0 | 7 | 5 | 4 |
| Operating Profit Margin % | 0.00% | 14.00% | 13.00% | 10.00% |
| Depreciation | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 5 | 4 | 3 |
| Tax | 0 | 0 | -1 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| Earnings Per Share (₹) | 0.00 | 8.27 | 8.07 | 4.18 |
Related Pages for Indo Us Bio-Tech
Additional stock information and data for INDOUS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2022 | 2021 | 2020 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 56 | 44 | 35 |
| Current Assets | 47 | 38 | 32 |
| Fixed Assets | 6 | 2 | 1 |
| Capital Work in Progress | 2 | 2 | 1 |
| Investments | 0 | 0 | 0 |
| Other Assets | 48 | 39 | 32 |
| LIABILITIES | |||
| Total Liabilities | 56 | 44 | 35 |
| Current Liabilities | 5 | 4 | 2 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 39 | 21 | 16 |
| Share Capital | 9 | 6 | 6 |
| Reserves & Surplus | 29 | 15 | 10 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2022 | March 2021 | March 2020 |
|---|---|---|---|
| Operating Activities | 3 | 0 | -1 |
| Investing Activities | -5 | -2 | -1 |
| Financing Activities | 3 | 2 | 2 |
| Net Cash Flow | 0 | 0 | 0 |